Remove tag legislation
article thumbnail

STAT+: Colorado lawmakers revise effort to exempt rare disease drugs from state cost caps

STAT

The new legislation would also allow another state entity, the Rare Disease Advisory Council, to review such drugs in hopes of giving more voice to patients. The original bill was introduced over concerns that patients may lose access to rare disease drugs if companies halt sales or decide not to invest in developing such medicines.

105
105
article thumbnail

Drug Regulatory Affairs Certificate Institutes in India

Pharma Tutor

Historical Overview of Pharmaceutical Industries and Regulatory Affairs:During 1950s, multiple tragedies i.e., sulfanilamide elixir, vaccine tragedy and thalidomide tragedy have resulted in substantial increase of legislations for drug products quality, safety and efficacy. Mon, 07/18/2022 - 15:31.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Anti-Counterfeiting Technologies in Healthcare

Roots Analysis

Examples of such technologies include DNA Taggants (a unique DNA tag used in the product / packaging that can be scanned using a designated instrument / equipment), invisible printing technologies, digital watermark technologies and hidden markers / print technologies.

article thumbnail

Rare Disease Spotlight – tracing the rise of orphan drug designations over almost 40 years

Pharmaceutical Technology

Almost 40 years since it was instituted, some have described the FDA’s orphan drug program, which is meant to foster innovation, as “ one of the most successful US legislative actions in recent history ”. Others judge its success based on the fact that 95% of rare diseases still have no available therapies and patient needs remain unmet.

article thumbnail

Orphan drugs’ financial success raises questions

pharmaphorum

And of course, in many cases, these drugs have higher than average price tags compared to the wider market which is due to the limited – or in most cases – non-existent competition within a treatment area.”. Raising questions. While in the US, Congress has proposed limits to the Orphan Drug Tax Credit, as part of the Build Back Better Act.

article thumbnail

A history of Pfizer

pharmaphorum

“Pfizer is the 6th largest lobbier in Washington, and spent $25 million on lobbying during the passing of Obama’s healthcare reform legislation alone” Ups and downs. For all the latest Pfizer news follow pharmaphorum’s Pfizer tag. The post A history of Pfizer appeared first on.

article thumbnail

Sanders' latest bill devotes billions to primary care, clinician training. Republicans, hospitals aren't on board

Fierce Healthcare

The influential Democrat's legislation is slated for committee markup next week, but is already being speared by Republicans for its price tag and hospitals for measures requiring site-neutral payments. Senate Health, Education, Labor and Pensions (HELP) Committee Chair Sen. |